Phase 3 Primary Biliary Cholangitis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• You must be willing and able to sign and date a consent form agreeing to take part in the study
• You must have already completed a previous clinical trial studying fenofibrate for a liver condition called PBC (trial number NCT05751967)
• If you are a woman who could become pregnant, you must agree to use at least one barrier method of contraception (such as a condom or diaphragm) plus a second form of birth control during the study and for at least 90 days after your last dose
• If you are a man who is sexually active with a woman who could become pregnant, you must use a barrier method of contraception, and your partner must also use a second form of birth control during the study and for at least 90 days after your last dose

Who may not be able to join:

• If you had to stop taking the study drug in a previous PBC trial due to a harmful side effect caused by the treatment, you may not be eligible
• If you have another health condition (apart from PBC) that the study doctor believes would prevent you from fully taking part in the study or could affect the results, you may not be eligible

Important: Always verify eligibility with the trial site directly before applying.